Characterization of the toxicity, mutagenicity, and carcinogenicity of methacrylonitrile in F344 Rats and B6C3F1 mice.
Methacrylonitrile is an unsaturated aliphatic nitrile. It is widely used in the preparation of homopolymers and copolymers, elastomers, and plastics, and as a chemical intermediate in the preparation of acids, amides, amines, esters, and other nitriles. Methacrylonitrile was nominated for study by the National Cancer Institute (USA) because of the potential for human exposure, structural similarity to the known carcinogen acrylonitrile, and a lack of toxicity and carcinogenicity data. Doses selected for the 2-year study were based on the results of the 13-week gavage studies. Groups of 50 male and 50 female animals were exposed by gavage to 0, 3, 10, or 30 mg/kg in F344 rats, and 0, 1.5, 3 or 6 mg/kg in B6C3F1 mice, 5 days per week for 2 years. Urinary excretion of N-acetyl- S-(2-cyanopropyl)- l-cysteine (NACPC) and N-acetyl- S-(2-hydroxypropyl)- l-cysteine (NAHPC) were measured as markers of exposure at various time points after methacrylonitrile administration, and demonstrated that exposure of animals to methacrylonitrile occurred as intended. Urinary excretion of NACPC and NAHPC increased in rats and mice in a dose-dependent manner. In contrast to observations in rats, the ratios of NACPC/creatinine were generally higher in female than in male mice. Further, the ratios of NAHPC/creatinine in rats were significantly greater at all time points and all doses than the corresponding ratios of NACPC/creatinine in male and female mice. In both rats and mice, survival was not affected by treatment. In rats, mean body weights of the 30 mg/kg groups were less than those of the vehicle controls after weeks 21 and 37 for males and females, respectively. No treatment-related effect on body weight was seen in mice. There were no neoplasms (in either species) or non-neoplastic lesions (mice only) that were attributed to methacrylonitrile administration. In rats, the incidences of olfactory epithelial atrophy and metaplasia of the nose were significantly greater in 30 mg/kg males and females than those in the vehicle controls. Increased incidences of cytoplasmic vacuolation occurred in the liver of males and females. Testing methacrylonitrile in a battery of short-term in vitro and in vivo tests showed no evidence of genotoxicity. In conclusion, under the conditions of these 2-year gavage studies, there was no evidence of a carcinogenic activity of methacrylonitrile in male or female F344/N rats or B6C3F1 mice. Methacrylonitrile-related non-neoplastic lesions were seen in the nose and liver of rats.
Nyska
Abraham
A
Laboratory of Experimental Pathology, MD B3-06, Environmental Toxicology Program, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health, PO Box 12233, Research Triangle Park, NC 27709, USA. nyska@niehs.nih.gov
Ghanayem
Burhan I
BI
D000284:Administration, Oral; D000818:Animals; D015415:Biomarkers / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D002273:Carcinogens / Q000633:toxicity*; D003404:Creatinine / Q000652:urine; D003593:Cytoplasm / Q000187:drug effects / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D004781:Environmental Exposure; D005260:Female; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008297:Male; D008689:Methacrylates / Q000008:administration & dosage / Q000378:metabolism / Q000633:toxicity*; D051379:Mice; D008815:Mice, Inbred Strains; D009153:Mutagens / Q000633:toxicity*; D009570:Nitriles / Q000008:administration & dosage / Q000378:metabolism / Q000633:toxicity*; D009831:Olfactory Mucosa / Q000187:drug effects / Q000473:pathology; D051381:Rats; D011916:Rats, Inbred F344; D018675:Toxicity Tests; D014617:Vacuoles / Q000187:drug effects / Q000473:pathology
D015415:Biomarkers; D002273:Carcinogens; D008689:Methacrylates; D009153:Mutagens; D009570:Nitriles; C008385:methacrylonitrile; D003404:Creatinine